Ethyl 6-chloro-1H-indazole-3-carboxylate is primarily used in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active compounds. Its indazole core structure makes it valuable in the creation of potential drug candidates, particularly in the fields of oncology and anti-inflammatory therapies. Researchers utilize this compound to develop molecules that target specific enzymes or receptors, aiding in the discovery of new treatments for diseases. Additionally, it serves as a building block in organic synthesis, enabling the production of more complex chemical entities with potential therapeutic applications.